Yawnnnnnnn will this $hit of a beast ever do anything....couldn't even get .005 for the rights issue, oh well at least someone is happy to pay .0048 where on market the buyers are at .003
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%